<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02281305</url>
  </required_header>
  <id_info>
    <org_study_id>22977 / 29-08-2014</org_study_id>
    <nct_id>NCT02281305</nct_id>
  </id_info>
  <brief_title>Post-MI PET Scan Imaging of Inflammation</brief_title>
  <official_title>Imaging of Inflammation in the Postischemic Myocardium: Effect of Anti-inflammatory Treatment With Colchicine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>G.Gennimatas General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academy of Athens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>G.Gennimatas General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Restoring the patency of the coronary vessels and providing the ischemic myocardium with
      reperfused blood can cause additional tissue damage. A key element of ischemia and
      reperfusion (I/R) injury and major determinant of the evolution of damage in the affected
      myocardium is the inflammatory response. The main objective of the study is to evaluate the
      efficacy of colchicine in reducing I/R injury by effectively modulating the inflammatory
      response in the reperfused myocardium.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of inflammation of the involved myocardium as assessed by the PET scan</measure>
    <time_frame>5 days post-MI</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Colchicine Active treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug: Colchicine 2 mg loading dose; 0.5 mg bid for 5 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Drug: Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colchicine</intervention_name>
    <arm_group_label>Colchicine Active treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The study will enroll patients 18 years old or older

          -  Who presented to the hospital within twelve (12) hours of the onset of chest pain -Who
             had ST segment elevation &gt; 1 mm in two contiguous limb leads or ST segment elevation &gt;
             2 mm in two consecutive precordial leads or new onset of left bundle branch block
             (LBBB) in a twelve lead electrocardiogram and for whom the decision was made to be
             taken to the cath lab to perform angioplasty of the coronary vessels.

        Exclusion Criteria:

          -  Excluded patients:

               -  with age &gt; 80 years old

               -  with active inflammatory diseases, infectious diseases or known malignancy

               -  under treatment with corticosteroids, anti-inflammatory agents or disease
                  modifying agents

               -  with known hypersensitivity-allergy to colchicine

               -  under chronic treatment with colchicine

               -  with severe renal failure (eGFR &lt; 30 ml/min/1.73 m2)

               -  with hepatic failure (Child - Pugh class B or C)

               -  presented with cardiac arrest

               -  presented with ventricular fibrillation

               -  presented with cardiogenic shock

               -  with stent thrombosis

               -  with angina within 48 hours before infarction

               -  with previous myocardial infarction in the affected territory

               -  with occlusion of the left main or left circumflex coronary or the right coronary
                  artery or with evidence of coronary collaterals to the region at risk on initial
                  coronary angiography (at the time of admission)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Constantinos Anagnostopoulos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Biomedical Research Foundation of Academy of Athens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christos Angelidis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Athens General Hospital &quot;G. Gennimatas&quot;</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Spyridon Deftereos, MD</last_name>
    <phone>+302107768560</phone>
    <email>spdeftereos@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Georgios Giannopoulos, MD</last_name>
    <phone>+302107768560</phone>
    <email>ggiann@med.uoa.gr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Athens General Hospital &quot;G. Gennimatas&quot;</name>
      <address>
        <city>Athens</city>
        <state>Attika</state>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>spyridon Deftereos, MD</last_name>
      <phone>+302107768560</phone>
      <email>spdeftereos@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 30, 2014</study_first_submitted>
  <study_first_submitted_qc>October 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2014</study_first_posted>
  <last_update_submitted>October 31, 2014</last_update_submitted>
  <last_update_submitted_qc>October 31, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>G.Gennimatas General Hospital</investigator_affiliation>
    <investigator_full_name>Spyridon Deftereos</investigator_full_name>
    <investigator_title>Director, Cardiac Catheterization Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colchicine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

